These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 20874499)

  • 1. Bimatoprost 0.03% versus brimonidine 0.2% in the prevention of intraocular pressure spike following neodymium:yttrium–aluminum–garnet laser posterior capsulotomy.
    Artunay O; Yuzbasioglu E; Unal M; Rasier R; Sengul A; Bahcecioglu H
    J Ocul Pharmacol Ther; 2010 Oct; 26(5):513-7. PubMed ID: 20874499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fixed combination brimonidine-timolol versus brimonidine for treatment of intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Öner V; Alakuş MF; Taş M; Türkyılmaz K; Işcan Y
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):576-80. PubMed ID: 22809091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brimonidine 0.2% versus brimonidine Purite 0.15%: prophylactic effect on iop elevation after Nd:YAG laser posterior capsulotomy.
    Yeom HY; Lee JH; Hong YJ; Seong GJ
    J Ocul Pharmacol Ther; 2006 Jun; 22(3):176-81. PubMed ID: 16808678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brimonidine 0.15% versus apraclonidine 0.5% for prevention of intraocular pressure elevation after anterior segment laser surgery.
    Chen TC
    J Cataract Refract Surg; 2005 Sep; 31(9):1707-12. PubMed ID: 16246772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apraclonidine 0.5% versus brimonidine 0.2% for the control of intraocular pressure elevation following anterior segment laser procedures.
    Chevrier RL; Assalian A; Duperré J; Lesk MR
    Ophthalmic Surg Lasers; 1999 Mar; 30(3):199-204. PubMed ID: 10100253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brinzolamide 1% versus apraclonidine 0.5% to prevent intraocular pressure elevation after neodymium:YAG laser posterior capsulotomy.
    Unal M; Yücel I; Akar Y
    J Cataract Refract Surg; 2006 Sep; 32(9):1499-502. PubMed ID: 16931262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the effects and safety of dorzolamide hydrochloride + timolol maleate versus brimonidine after neodymium-doped yttrium aluminium garnet laser capsulotomy posterior capsule opacification.
    Çakmak K; Erbil H; Mesci C; Korkmaz Ş
    Eur J Ophthalmol; 2022 Sep; 32(5):2928-2934. PubMed ID: 34791912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 0.2% brimonidine in preventing intraocular pressure elevation after Nd:YAG laser posterior capsulotomy.
    Seong GJ; Lee YG; Lee JH; Lim SJ; Lee SC; Hong YJ; Kwon OW; Kim HB
    Ophthalmic Surg Lasers; 2000; 31(4):308-14. PubMed ID: 10928668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prophylactic effect of betaxolol 0.5% versus brimonidine 0.2% on IOP elevation after Nd:YAG laser posterior capsulotomy.
    Elmi Sadr N; Saber E; Paknazar F
    Clin Exp Optom; 2022 Nov; 105(8):813-816. PubMed ID: 34753412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of topical brimonidine to prevent intraocular pressure elevations following Nd:YAG-laser posterior capsulotomy.
    Gartaganis SP; Mela EK; Katsimpris JM; Petropoulos JK; Karamanos NK; Koliopoulos JX
    Ophthalmic Surg Lasers; 1999; 30(8):647-52. PubMed ID: 10507567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bimatoprost on intraocular pressure after cataract surgery.
    Unal M; Yücel I
    Can J Ophthalmol; 2008 Dec; 43(6):712-6. PubMed ID: 19020639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.
    Chen TC; Ang RT; Grosskreutz CL; Pasquale LR; Fan JT
    Ophthalmology; 2001 Jun; 108(6):1033-8. PubMed ID: 11382625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE; Lai J
    Ophthalmology; 2009 Sep; 116(9):1719-24. PubMed ID: 19592108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prophylactic intraocular pressure-lowering medication on pain during cataract surgery.
    Ulaş F; Balbaba M; Çelebi S
    J Ocul Pharmacol Ther; 2013 Sep; 29(7):658-62. PubMed ID: 23461283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of latanoprost, bimatoprost, and travoprost on intraocular pressure after cataract surgery.
    Arici MK; Erdogan H; Toker I; Vural A; Topalkara A
    J Ocul Pharmacol Ther; 2006 Feb; 22(1):34-40. PubMed ID: 16503773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term elevation of intraocular pressure after neodymium: YAG laser posterior capsulotomy.
    Jahn CE; Emke M
    Ophthalmologica; 1996; 210(2):85-9. PubMed ID: 9148259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Study of Intraocular Pressure following Neodynium Yttrium Aluminium Garnet Laser Capsulotomy with the Use of Brimonidine: A Descriptive Cross-sectional Study.
    Manandhar LD; Gurung N; Shrestha K; Bhattarai B; Godar M; Shrestha R
    JNMA J Nepal Med Assoc; 2021 Jan; 59(233):15-18. PubMed ID: 34508462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bimatoprost versus travoprost in an Egyptian population: a hospital-based prospective, randomized study.
    Macky TA
    J Ocul Pharmacol Ther; 2010 Dec; 26(6):605-10. PubMed ID: 21034177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient optic disc edema following neodymium: yttrium-aluminum-garnet laser posterior capsulotomy.
    Han SB; Yang HK; Hyon JY; Woo SJ; Wee WR
    Can J Ophthalmol; 2012 Feb; 47(1):e1-2. PubMed ID: 22333862
    [No Abstract]   [Full Text] [Related]  

  • 20. Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty.
    David R; Spaeth GL; Clevenger CE; Perell HF; Siegel LI; Henry JC; Stiles MC; Passo MS; Stamper RL; Walt JG
    Arch Ophthalmol; 1993 Oct; 111(10):1387-90. PubMed ID: 8105773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.